
Johnson&Johnson
Financials
Market Cap
$401.17B5Y beta
0.54EPS (TTM)
$4.78Free Float
2.60BP/E ratio (TTM)
32.29Revenue (TTM)
$96.26BEBITDA (TTM)
$34.29BFree Cashflow (TTM)
$4.37BPricing
Open
n/aClose
n/aAnalyst Ratings
The price target is $179.58 and the stock is covered by 20 analysts.
Buy
8
Hold
12
Sell
0
Information
Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.